Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-11-27

FDA Approved: SILVER SULFADIAZINE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Silver Sulfadiazine by Ascend Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silvadene (silver sulfadiazine)

Snippet

SUPPL AP for SILVER SULFADIAZINE (SILVER SULFADIAZINE)